Coming Soon

Tecrea Limited

Registration Number 07966622

Trading name: Tecrea

Tecrea specializes in providing innovative technology solutions and consulting services to optimize business processes, enhance operational efficiency, and drive digital transformation across various industries.

Company Overview

Company Name
Tecrea Limited
Registration Number
07966622
Founded
27 February 2012
Age
12 years
Industry Region
London
Registered Postcode
NW1 0NH

Online Profile

Special Flags

Spinout Company
Public Funding Received

Public Funding for Tecrea Limited

2021-05-01
Scalable AAV production in high density suspension HEK293SF-3F6 cell culture using Nanocin transfection
Collaborative R&D
2020-08-01
Development of a coupled inactivating transport medium and RNA purification protocol for SARS-CoV-2
Collaborative R&D
2018-05-01
Improving ophthalmic drug delivery by novel formulations: peptidic hydrogels and nanoparticles
Feasibility Studies
2017-06-01
Track and measure polymeric nanoparticles
Collaborative R&D
2015-05-01
Scalable AAV Production using Novel Hollow Fibre Bioreactors
Feasibility Studies
2014-08-01
Modulating intracellular oncology targets using Adhirons™ – a novel therapeutic approach
Feasibility Studies
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2013-08-01
Formulation of messenger RNA for Intracellular Delivery and Expression
Feasibility Studies
2013-08-01
Formulation and stability of biological products for skin delivery focussing on Retinol.
Feasibility Studies
2012-11-01
IP protection of Nanocin for Infectious Disease Therapy
Vouchers
2012-08-01
Non-toxic Platform for Biomolecule Delivery into Cells
Feasibility Studies

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.